Open-house rebate agreement for Timolol

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Dec 03, 2027 · 462 days left·Open·Supplies·Framework

Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Timolol, ATC S01ED01

46/100

Opportunity Score

Needs reviewMedium complexity

SuppliesFrameworkOpen

Why this score?

Opportunity

46 / 100

Complexity

58 / 100

Risk factors

Contract documents must be submitted in the DTVP communication area, not in the offer area; using the wrong channel cou...

The latest contract conclusion date is 2027-12-03, and monthly cut-off rules apply for next-month start dates.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Overview

Moderate opportunity

Key Facts

Framework procurement
Supplies contract
1 lot
Duration until Jan 2028
Non-exclusive rebate agreement for Timolol, ATC S01ED01.
Supply of pharmaceutical products under an open-house model.

Show full summary

This is an open-house pharmaceutical supply arrangement for Timolol (ATC S01ED01) led by AOK Bayern. It is not a competitive award procedure in the usual sense: the notice states that all interested pharmaceutical companies meeting the stated eligibility condition may conclude identical, non-negotiable, non-exclusive rebate agreements. The contract period runs from 2026-02-01 to 2028-01-31, with contract entry possible until 2027-12-03. Submission is via DTVP electronic communication area or by paper originals in duplicate; German language is required, and non-German documents need a German translation.

Risks

Contract documents must be submitted in the DTVP communication area, not in the offer area; using the wrong channel cou...

The latest contract conclusion date is 2027-12-03, and monthly cut-off rules apply for next-month start dates.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

Applicant must be a pharmaceutical company.

Administrative

Signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit) must be submitted.
Signed contract and completed annex 'Festlegung der vertragsgegenständlichen Arzneimittel' must be submitted.

Buyer

Name

AOK Bayern - Die Gesundheitskasse

Location

München, DEU

[email protected]

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open-house rebate agreement for Timolol

Open-house supply arrangement for the pharmaceutical product Timolol, ATC S01ED01. The lot scope is a non-exclusive rebate agreement for interested pharmaceutical companies; the notice says the contract terms are fixed and not individually negotiable. Place of performance is Germany, Bavaria (DE212).

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Jan 2026 - Jan 2028

Procurement Details

Publication date: 14 Dec 2025
Languages: German

Reference metadata

Legal basis: 32014L0024

Reference IDs

Tender ID: 829522-2025

Documents (2)

Procurement document 1 Submission portal 1

Similar tenders

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3